Griffyn Robotech Will Manufacture and Supply Mass Ventilators to the Government of India

▴ Griffyn Robotech Will Manufacture and Supply Mass Ventilators to the Government of India
Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients

With COVID-19 cases multiplying at an alarming rate, Griffyn Robotech, an Artificial Intelligence (AI) innovations company headquartered in Pune, has announced manufacturing and mass supply of ventilators to support the Government of India in the fight against COVID-19 virus. The lethal coronavirus is known to affect the respiratory system of the patient who is required to be put on a ventilator, a machine that adds pressure to pump oxygen into the bloodstream and take out carbon dioxide from the lungs of the patient.

According to estimates by Government of India, the country needs 50,000 ventilators over the next two months. While the government has fast-tracked imports, the bulk of this shortfall has to be met by domestic manufacturers to fulfill the supply and demand gap. In this hour of crisis, Griffyn Robotech, with its other partners, scheduled for a Webex meeting to discuss the impact of the pandemic and initiatives that can be implemented to help the nation. The company was inspired by MIT ventilator design and created its own design using 3D printing technology to bring to the market 'Shwaas' an Ambu-bag based ventilator in the fight against COVID-19.

Speaking about the AI enabled ventilator, Mr. Amit Mahajan, Founder & CEO of Griffyn Robotech Pvt. Ltd., said, "Ventilators and other respiratory aids are critical devices in the fight against COVID-19, and to this end we are working together with our partners to ensure manufacturing and steady supply of ventilators in India. As a socially responsible and caring brand, we are committed to serving society in every way possible."

"Further to this effect, we will be creating an open API and extensible platform that can be leveraged for extended features to be rapidly introduced in next few weeks. We are also planning to collaborate with other start-ups for creating addons to the platform. We are all proud 'Desh Bhakts' and are glad to contribute with our skills so that we all win together the fight against the pandemic."

He further adds, "We will be applying to be one of the many suppliers to the government to manufacture ventilators on a large scale that can save millions of lives across India and globally to combat the COVID-19 pandemic. This will ensure we have enough ventilators and are prepared to tackle the coronavirus outbreak."

Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients with respiratory illnesses during emergencies and mass casualties, as an alternative for prolonged manual ventilation.

As per recent reports, India which only spends about 1 per cent of its gross domestic product on healthcare, has allocated fewer than 20,000 ventilators for the treatment of COVID-19 patients. The public health research organisation, based in Washington and New Delhi, estimates India will need as many as 1m ventilators to address the peak of coronavirus cases.

Tags : #Griffynrobotech #Massventilators #AI

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024